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Infections caused by Candida species have increased worldwide substantially over the latest decades, and are a significant cause of morbidity 
and mortality, mostly among critically ill patients. Candida glabrata is the second most common Candida responsible for these infections in the 
USA and the third in Europe, and is characterized by a high antifungal resistance. 
-  To understand the role of mannans in C. glabrata biofilms and in biofilm cells resistance to antifungal drugs 
(fluconazole - Flu, amphotericin B - AmB, caspofungin - Csf and micafungin - Mcf). 
1.  Biofilm structure: 
§  Confocal microscopy 
 
2.  Biofilm matrix analysis: 
§  Biomass reduction (Crystal Violet) 
§  Mannans (Quantitative Alcian Blue Binding Assay) 
§  Polysaccharides (Dubois method) 
§  β-1,3	glucans (Glucatell® Kit) 
§  The KO of the MNN2 gene does not reveals any microscopic changes in the cell wall; 
§  The lack of mannans leads to a more fragile biofilm and a higher biomass loss after a drug stress; 
§  The polysaccharides content increase in the biofilm matrix of C. glabrata strains in contact with Flu, AmB and Mcf, but the mannans have the 
opposite behavior; 
§  All the strains produce high quantitites of β-1,3 glucans when in the presence of all drugs, specially the mutant, which is probably attempting to 
compensate the lack of mannans in the matrix; 
§  C. glabrata Δmnn2  has a more fragile biofilm than the other strains, which can alter its drug resistance. 
ΔT=24 h pre-formed biofilms	
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% Biomass Reduction Flu 1250 AmB 4 Csf 3 Mcf 17 
C. glabrata ATCC2001 16% 52% 83% 57% 
C. glabrata HT6 49% 63% 60% 64% 
C. glabrata Δmnn2 67% 78% 75% 82% 
No variations on the cell wall 
were noticed among the strains 
But… the mutant and parent strains showed a higher 
amount of multilayer structures, than the reference 
strain 
Figure 1. Confocal laser scanning microscopy image a 48-hour-biofilm of C. glabrata ATCC2001 (A), C. glabrata HT6 (B) and C. glabrata Δmnn2 (C). The biofilm images were 
acquired using  a Confocal Scanning Laser Microscope (Olympus BX61, Model FluoView 1000). Filters: DAPI (100 mg/L emissions filters BA 430–470) and Concavalin A, Alexa Fluor 
488 conjugate (50 mg/L emissions filters BA 505–605).  Images were acquired with the program FV10-ASW 4.2 (Olympus) using a magnification of 100xm Measure bar: 10 µm.                     Polysaccharides tended to increase in the 
biofilm matrices of the strains in contact 
with all drugs, specially with Flu, AmB for C. 
glabrata HT6 and Mcf for C. glabrata Δmnn2 
(P>0,0001). 
The biofilm matrices showed to reduce their 
mannans content in the presence of all 
drugs in C. glabrata ATCC2001 and C. 
glabrata HT6.  
 
Interestingly, in C. glabrata Δmnn2 , these 
compounds were unable to be detected in 
the biofilm cell walls, in all conditions.  
Figure 4. β-1,3 glucans concentration on the biofilm matrices of C. glabrata 
ATCC2001, C. glabrata HT6 and C. glabrata Δmnn2. (Cg – C. glabrata) 
(* P<0.05; ** P<0.001; *** P<0.0005; **** P< 0.0001). 
β-1,3 glucans increased in the biofilm 
matrices of the strains in contact with all 
drugs, when compared to the control 
group. 
 
C. glabrata HT6 and the mutant, C. 
glabrata Δmnn2  showed to have the 
highest amounts in these sugars. 
Table 2. Percentages of biomass reduction of the biofilm matrices of C. glabrata ATCC2001, C. glabrata HT6 and C. glabrata Δmnn2 after  
ddding the  drugs and  comparing to the control group (0 mg/L). 
The lack of mannans leads to a more fragile biofilm a higher biomass loss. 
 
C. glabrata Δmnn2  presented the top biomass reduction, specially when in contact with 
echinocandins. 
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Change half medium and add: 
a.  RPMI-1640 (control group) 
b.  Antifungal: Flu, AmB, Csf or Mcf* 
(*at MBECs concentrations)	
 
C. glabrata strains: 
C. glabrata ATCC2001 (wild-type) 
C. glabrata HT6 (parent) 
C. glabrata Δmnn2 (mutant) 
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Figure 2. Polysaccharides content on the biofilm matrices of C. glabrata 
ATCC2001, C. glabrata HT6 and C. glabrata Δmnn2. (* P<0.05; **** P< 0.0001). 
(Cg – C. glabrata) 
Figure 3. Alcian Blue binding assay in biofilm matrices of C. glabrata ATCC2001, 
C. glabrata HT6 and C. glabrata Δmnn2. Data represent the percentage of 
amount of dye bound per biomass. (Cg – C. glabrata) 
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